Found vs Novi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Novi beats Found overall, scoring 7.8/10 vs 7.3/10. Novi is more affordable at $133/mo vs $264/mo. Choose Found for users who want a science-backed weight loss program with beh. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa.
A side-by-side comparison of Found and Novi covering pricing, scores, medication types, insurance, and more to help you decide.
Found
#36 of 46Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.
Visit FoundNovi
#14 of 46Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing — medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.
Visit Novi| Feature | Found | Novi |
|---|---|---|
| Our Score | 7.3/10 | 7.8/10 |
| Starting Price | $264/mo | $133/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | Yes | No |
| Best For | Users who want a science-backed weight loss program with behavior change support | Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer |
| Ranking | #36 | #14 |
Pros & Cons Compared
Found
Pros
- +Active insurance coordination — Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
- +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill) — the widest formulary of any platform
- +Typical insured copay of ~$30/mo for most members — dramatically lower than cash-pay alternatives
- +Most members start treatment within one week of completing the health questionnaire
Cons
- −Pricing is less transparent than flat-rate competitors — costs vary by insurance status and medication choice
- −The insurance navigation process adds steps and complexity compared to simple cash-pay platforms
- −Compounded medication availability may shift with FDA enforcement changes
Novi
Pros
- +Six disclosed clinicians on staff — Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP) — more named providers than most compounded-only platforms publish
- +Month-to-month billing with no minimum commitment — cancel before any renewal date with no early-termination penalty
- +Aggressive promotional pricing on the offer landing — $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
- +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
- +Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
- +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal
Cons
- −Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
- −Founding year, headquarters city, and corporate ownership are not publicly disclosed
- −Promotional $99-$133 pricing applies to the introductory offer landing only — standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
- −Once medication is dispensed/shipped, prescriptions cannot be returned or refunded — typical for compounded telehealth but worth understanding
- −Lab requirements before prescribing are not disclosed on public pages — unclear whether baseline bloodwork is required
- −Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout
Our Verdict
Novi edges out Found with a score of 7.8/10 vs 7.3/10. If budget is your priority, Novi starts at $133/mo compared to Found's $264/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Found offers both brand-name and compounded medications, giving you more flexibility. Choose Found if you want: users who want a science-backed weight loss program with behavior change support. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer.